Keith Orford, Chief Medical Officer at Calithera Biosciences, Inc. (CALA), sold 1,565 shares at $6.00 ($9K) on 2019-03-11, disclosed to the SEC on 2019-03-13.
Scheduled sale ($9k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CALA | SELL | 2020-12-18 | $15K | — | Filing → |
| CALA | SELL | 2020-02-24 | $24K | — | Filing → |
| CALA | SELL | 2019-12-26 | $18K | — | Filing → |